Cargando…
Tunable Emissive Ir(III) Benzimidazole‐quinoline Hybrids as Promising Theranostic Lead Compounds
Bioactive and luminescent cyclometallated Ir(III) complexes [Ir(ppy)(2) L1]Cl (1) and [Ir(ppy)(2) L2]Cl (2) containing a benzimidazole derivative (L1/L2) as auxiliary mimic of a nucleotide have been synthesised. The emissive properties of both complexes are conditioned by the nature of L1 and L2, re...
Autores principales: | Redrado, Marta, Miñana, Miriam, Coogan, Michael P., Concepción Gimeno, M., Fernández‐Moreira, Vanesa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796238/ https://www.ncbi.nlm.nih.gov/pubmed/35767349 http://dx.doi.org/10.1002/cmdc.202200244 |
Ejemplares similares
-
Dual Emissive Ir(III) Complexes for Photodynamic Therapy and Bioimaging
por: Redrado, Marta, et al.
Publicado: (2021) -
Multifunctional Heterometallic Ir(III)−Au(I) Probes as Promising Anticancer and Antiangiogenic Agents
por: Redrado, Marta, et al.
Publicado: (2021) -
Luminescent Bimetallic Ir(III)/Au(I) Peptide Bioconjugates as Potential Theranostic Agents
por: Luengo, Andrés, et al.
Publicado: (2020) -
From Sensors to Silencers: Quinoline- and Benzimidazole-Sulfonamides as Inhibitors for Zinc Proteases
por: Rouffet, Matthieu, et al.
Publicado: (2010) -
Photocatalytic Aerobic Dehydrogenation of N-Heterocycles
with Ir(III) Photosensitizers Bearing the 2(2′-Pyridyl)benzimidazole
Scaffold
por: Echevarría, Igor, et al.
Publicado: (2022)